Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Valentina Ungaro"'
Autor:
Mariarita Laforgia, Loredana Amodio, Santina Colangiulo, Valentina Ungaro, Letizia Gatti, Gianpiero Lucarelli, Marcello Leopoldo, Patrizia Nardulli, Nicola A. Colabufo
Publikováno v:
ACS Omega, Vol 7, Iss 29, Pp 25239-25243 (2022)
Externí odkaz:
https://doaj.org/article/dab9d1184c694ac2b4685d68f8dd90a9
Autor:
Antonella Argentiero, Antonio Giovanni Solimando, Valentina Ungaro, Mariarita Laforgia, Sabino Strippoli, Dario Pinto, Antonio Negri, Simona Ferraiuolo, Alfredo Zito, Michele Guida
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Recent advances in tumor immunotherapy have made it possible to efficiently unleash immune effectors, reacting against neoplastic cells. Although these approaches primarily aim to eradicate malignancy, immune-related adverse events (irAEs) often infl
Externí odkaz:
https://doaj.org/article/3082fae629c74b70b84b357fc7b3034c
Autor:
Alessandro, Rizzo, Riccardo, Carloni, Angela Dalia, Ricci, Antonio, Cusmai, Mariarita, Laforgia, Concetta, Calabrò, Valentina, Ungaro, Donato, Oreste, Mario, Sollitto, Gennaro, Palmiotti, Giovanni, Brandi
Publikováno v:
Expert Opinion on Drug Safety. 22:323-329
Despite all the improvements achieved over the last decade, the use of immune checkpoint inhibitors (ICIs) has been associated to a wide range of adverse drug events, which are frequently markedly different from those observed with cytotoxic chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da4a652d8ad1db6e65376b945b68004
https://doi.org/10.1080/14740338.2023.2152793
https://doi.org/10.1080/14740338.2023.2152793
Autor:
Simona Ferraiuolo, Patrizia Nardulli, Carmelo Laface, Concetta Calabrò, Valentina Ungaro, Mariarita Laforgia, Domenico Tricarico, Girolamo Ranieri, Cosmo Damiano Gadaleta
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 1980, p 1980 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 1980, p 1980 (2021)
Peripheral neurologic complications are frequent adverse events during oncologic treatments and often lead to dose reduction, administration delays with time elongation of the therapeutic plan and, not least, worsening of patients’ quality of life.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9219febd207605dbb63a48a15cfde692
http://europepmc.org/articles/PMC7922628
http://europepmc.org/articles/PMC7922628
Autor:
Alessandro, Rizzo, Antonio, Cusmai, Francesco, Giovannelli, Silvana, Acquafredda, Lucia, Rinaldi, Andrea, Misino, Elisabetta Sara, Montagna, Valentina, Ungaro, Mariagrazia, Lorusso, Gennaro, Palmiotti
Publikováno v:
Cancers. 14:1404
(1) Background: In recent years, immunotherapy has revolutionized the treatment landscape of non-small cell lung cancer (NSCLC), representing a therapeutic breakthrough in this field. Antacid agents such as proton pump inhibitors (PPIs) and histamine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d5f950d59229238cec00ca992713ad6
https://doi.org/10.3390/cancers14061404
https://doi.org/10.3390/cancers14061404